Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| 1 |
Linde
LIN
|
+$397M |
| 2 |
NVIDIA
NVDA
|
+$373M |
| 3 |
AT&T
T
|
+$295M |
| 4 |
Energy Select Sector SPDR Fund
XLE
|
+$274M |
| 5 |
Walmart
WMT
|
+$273M |
Top Sells
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.19B |
| 2 |
Lam Research
LRCX
|
+$379M |
| 3 |
Apple
AAPL
|
+$367M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$320M |
| 5 |
Boeing
BA
|
+$299M |
Sector Composition
| 1 | Technology | 16.96% |
| 2 | Healthcare | 16.1% |
| 3 | Financials | 12.4% |
| 4 | Consumer Discretionary | 11.37% |
| 5 | Industrials | 11.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3351
Vanguard International High Dividend Yield ETF
VYMI
$12.4B
| $504K | ﹤0.01% |
+8,136
| New | +$504K |
|
3352
Pixelworks
PXLW
$54.5M
| $503K | ﹤0.01% |
28,298
-12,867
| -31% | -$229K |
|
3353
Abeona Therapeutics
ABEO
$289M
| $502K | ﹤0.01% |
177,955
+30,176
| +20% | +$85.1K |
|
|
EU
3354
enCore Energy
EU
$483M
| $501K | ﹤0.01% |
+226,762
| New | +$501K |
|
|
IMOS
3355
ChipMOS TECHNOLOGIES
IMOS
$659M
| $496K | ﹤0.01% |
+19,747
| New | +$496K |
|
3356
LeMaitre Vascular
LMAT
$2.09B
| $495K | ﹤0.01% |
+9,616
| New | +$495K |
|
3357
Monroe Capital Corp
MRCC
$164M
| $495K | ﹤0.01% |
64,648
-41,846
| -39% | -$320K |
|
3358
Oxford Square Capital
OXSQ
$162M
| $494K | ﹤0.01% |
156,310
-292,696
| -65% | -$925K |
|
|
MACK
3359
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
| $494K | ﹤0.01% |
40,204
+23,219
| +137% | +$285K |
|
3360
Pampa Energía
PAM
$3.27B
| $493K | ﹤0.01% |
14,945
-223,194
| -94% | -$7.36M |
|
3361
Aclaris Therapeutics
ACRS
$196M
| $492K | ﹤0.01% |
60,863
-147,035
| -71% | -$1.19M |
|
3362
BioAtla
BCAB
$39.8M
| $492K | ﹤0.01% |
183,687
+81,622
| +80% | +$219K |
|
|
LIAN
3363
DELISTED
LianBio American Depositary Shares
LIAN
| $490K | ﹤0.01% |
251,495
-69,023
| -22% | -$134K |
|
3364
Crescent Capital BDC
CCAP
$575M
| $488K | ﹤0.01% |
35,846
-53,645
| -60% | -$730K |
|
3365
Otis Worldwide
OTIS
$35.2B
| $488K | ﹤0.01% |
5,781
-77,550
| -93% | -$6.55M |
|
|
PMT
3366
PennyMac Mortgage Investment
PMT
$1.07B
| $488K | ﹤0.01% |
39,564
-255,951
| -87% | -$3.16M |
|
3367
Global X Lithium & Battery Tech ETF
LIT
$1.2B
| $487K | ﹤0.01% |
+7,668
| New | +$487K |
|
3368
Renasant Corp
RNST
$3.59B
| $487K | ﹤0.01% |
15,927
-493,040
| -97% | -$15.1M |
|
3369
Comtech Telecommunications
CMTL
$71.4M
| $486K | ﹤0.01% |
38,976
-12,179
| -24% | -$152K |
|
|
HARP
3370
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
| $486K | ﹤0.01% |
65,282
-58,347
| -47% | -$434K |
|
3371
iShares MSCI New Zealand ETF
ENZL
$75.3M
| $485K | ﹤0.01% |
+9,714
| New | +$485K |
|
3372
Astrana Health
ASTH
$1.34B
| $485K | ﹤0.01% |
+13,290
| New | +$485K |
|
3373
Gannett
GCI
$626M
| $484K | ﹤0.01% |
258,726
+27,763
| +12% | +$51.9K |
|
|
HLGN
3374
DELISTED
Heliogen, Inc.
HLGN
| $484K | ﹤0.01% |
57,544
-58,180
| -50% | -$489K |
|
3375
C4 Therapeutics
CCCC
$241M
| $482K | ﹤0.01% |
+153,556
| New | +$482K |
|